SeedRound Media
Rushed for time? Here is the top 5 Seed investors for Medical startups. Scroll down for more information on these investors or to view the rest of the investors.
Name | Website | Stages | Location | Socials |
|---|---|---|---|---|
Wellcome Trust | Early Stage Venture, Late Stage Venture, Private Equity, Seed | London, England, United Kingdom, Europe | ||
Pario Ventures | Convertible Note, Debt, Early Stage Venture, Secondary Market, Seed, Venture | London, England, United Kingdom, Europe | ||
Nova Growth Capital | Early Stage Venture, Seed | Liverpool, Liverpool, United Kingdom, Europe | ||
DigitalHealth.London Accelerator | Seed | London, England, United Kingdom, Europe | ||
Angels 5K | Early Stage Venture, Seed | Winchester, Hampshire, United Kingdom, Europe |
At SeedRound we track over 200,000 investors and over 1,000,000 people who hold key positions in these firms. We use this directory of investors to highlight top employees, LP’s and funding organisations we think deserve more appreciation than they are currently getting.
We’ve ranked the top Medical Seed investors in United Kingdom. The companies, startups and institutions listed in this article are all exceptional companies, well worth a follow. We have included links to their websites, socials and CrunchBase (if you’re interested in their financials).
We selected the organisations listed in this article based on:
- Track record
- Executive leadership
- Market share
- Innovation
- ESG rating
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Top Medical Investors & Funds (United Kingdom)
Wellcome Trust
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Stages: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Health Care, Medical, Non Profit
Follow:
Pario Ventures
Pario works with entrepreneurs, CEOs, and business owners to identify and implement an exit strategy for the founder or shareholder. Pario Ventures is also active in investment for the startup, scale phase, and then pre IPO. It was founded in 2010 by Kevin Doyle and David Murray-Hundley and is based in London, England, the United Kingdom with also an office in New York and Brussels.
Stages: Convertible Note, Debt, Early Stage Venture, Secondary Market, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Automotive, Blockchain, Drones, Fashion, Financial Services, Medical, Non Profit, Oil and Gas, Software, Space Travel
Follow:
Nova Growth Capital
Nova Growth Capital is an award-winning fund that invests in disruptive SEIS & EIS companies. Allowing investors to take advantage of a growth-focused and diversified investment portfolio. Its deal flow comes exclusively from its Cofoundery Nova, a venture builder that has seen 36.5% growth in its portfolio year on year for 12 years. Nova employs 100+ startup experts to actively source and grow their portfolio of tech enabled, disruptive SEIS & EIS companies. The fund is an opportunity to invest alongside Nova Cofoundery Limited (“Nova”) in their portfolio of early-stage companies. The Fund, therefore, seeks to benefit from co-investing with experienced partners. Investment Strategy: The Nova Growth Capital fund invests in ideas stage and early stage startups, without any capital investment from the founder. Nova’s programme will take the founder from an initial idea to discovering its market and building the product. Nova mentors, explores, validates & scales founders and their ideas. The Fund seeks to offer investors a diversified exposure of a minimum of ten investee companies each of which is engaged in solving industry problems with the use of a digital solution. It is envisaged that each subscription will be deployed across each investee company on a diversified basis, at the discretion of Nova Growth Capital Limited and Sapphire Capital Partners. Nova seeks to leverage appropriate technology to source and mentor potential founders. This gives Nova the capability to perform real “in-person” due diligence on their entrepreneurs before it co-invests, it allows Nova to understand and model the performance funnel and gives Nova control of deal flow. Nova typically sees over 25 opportunities per investment that are made. SEIS & EIS tax incentive: The companies the fund invest in are expected to be SEIS-EIS-qualifying, which makes Nova Cofoundery SEIS & EIS Fund SEIS-EIS suitable for qualifying clients who would potentially benefit from the following tax reliefs: – Up to 30% income tax relief (50% for SEIS) – Tax-free investment growth – Capital gains deferral (or 50% capital gains tax exemption for SEIS) – Inheritance tax relief – Loss relief We are proud that in the 12 years we have been building ventures through the Nova Cofoundery, we have invested in everything we have co-founded. Now private investors are able to invest alongside the Nova Group through our SEIS and EIS fund.
Stages: Early Stage Venture, Seed
Location: Liverpool, Liverpool, United Kingdom, Europe
Industries: Apps, EdTech, FinTech, Hardware, Health Care, Marketplace, Medical, Retail Technology, Software, Wellness
Follow:
Angels 5K
Angels 5K is a group of private investors based in the South of England. We focus on high growth business opportunities and have invested over £4 million of our own money to date in dozens of companies throughout the UK. We are entrepreneurs ourselves and are passionate about encouraging new businesses.
Stages: Early Stage Venture, Seed
Location: Winchester, Hampshire, United Kingdom, Europe
Industries: Life Science, Medical Device
Follow:
[email protected]
The aim of [email protected] is to support the development of science concepts and the creation of new companies by providing access to equipped communal laboratories on short-term agreements, as well as guidance from mentors and introductions to investors. The concept complements the Babraham Research Campus’ ongoing support of the Cambridge life science cluster through the provision of access to the campus community and infrastructure without the need to be an established occupier on site.
Stages: Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Biopharma, Biotechnology, Life Science, Medical
Follow:
Neo Kuma Ventures
Europe’s first venture capital firm to focus solely on investments into psychedelic healthcare companies. Ten investments already executed with more in the pipeline.
Stages: Convertible Note, Early Stage Venture, Late Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Financial Services, Health Care, Medical
Follow:
Future Care Capital
In pursuance of its charitable mission, Future Care Capital (FCC) will use its resources to identify and support innovation through the launch of a dedicated Innovation Fund. The Innovation Fund aims to help address major healthcare needs, such as mental health, ageing and living with chronic medical conditions, by investing in innovative enterprises. It will also have an ethical investment policy that will drive its activities in compliance with the charity’s policies and aims. The Fund will invest in UK based, early-stage, high-tech, high-growth enterprises in the field of digital health (including machine learning and AI), assisted living, services and Class I medical devices.
Stages: Early Stage Venture, Seed, Venture
Location: London, England, United Kingdom, Europe
Industries: Biotechnology, Health Care, Life Science, Medical, Pharmaceutical
Follow:
Epiphany Capital
Over £110m raised for clients at Seed, Series A & B, originated/executed numerous secondary transactions, advised startup teams through exits to major global corporates. Based in Manchester, United Kingdom – operational around Europe.
Stages: Early Stage Venture, Seed, Venture
Location: Manchester, Manchester, United Kingdom, Europe
Industries: Artificial Intelligence, Consumer, E-Commerce, Enterprise Software, FinTech, Medical Device, SaaS, Smart Cities, Smart Home, Venture Capital
Follow:
Wayra & Novartis Health Call
We scale start-ups. We are now looking for our next cohort of remarkable start-ups to join our new programme called The Health Hub, built together with our partner Novartis, one of the leading pharma companies in the world. Our focus is on how Health Tech can be used to drastically innovate long-term disease management.
Stages: Seed
Location: London, England, United Kingdom, Europe
Industries: Advice, Health Care, Medical, Pharmaceutical, Training
Follow:
